Brief: Modus Therapeutics Secures Bridge Financing From Karolinska Development

Modus Therapeutics Holding AB

29/03/2023 12:50

March 29 (Reuters) - Modus Therapeutics Holding AB
 MODTX.ST :
    * MODUS THERAPEUTICS SECURES ACCESS TO BRIDGE FINANCING FROM
LONGSTANDING INVESTOR KAROLINSKA DEVELOPMENT
    * ACCESS TO THIS FUNDING ENSURES THAT MOMENTUM OF CLINICAL
DEVELOPMENT OF SEVUPARIN WILL BE ENHANCED
    * FUTURE DEVELOPMENT PLANS INCLUDE PREPARATION FOR A PHASE
2A
STUDY EVALUATING SEVUPARIN FOR TREATMENT OF SEPSIS, EXPECTED TO
COMMENCE AT END OF 2023

Source text for Eikon:  ID:nMFN1p7p9k 
Further company coverage:  MODTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))